Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rubin

Showing results (451-460 of 1,971) with videos related to

Pageof 198
Sort By:
The New England Journal of Medicine|August 11, 2021
Audio Interview: Monoclonal Antibodies and Booster ShotsEric J Rubin, Lindsey R Baden, Stephen Morrissey
The New England Journal of Medicine|August 4, 2021
Audio Interview: Looking Back and Looking Forward - Part 2Eric J Rubin, Lindsey R Baden, Stephen Morrissey
The New England Journal of Medicine|February 10, 2021
Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing?Eric J Rubin, Lindsey R Baden, Stephen Morrissey
The New England Journal of Medicine|December 22, 2021
Audio Interview: A Potential New Agent to Treat Covid-19Eric J Rubin, Lindsey R Baden, Stephen Morrissey
The New England Journal of Medicine|December 15, 2021
Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?Eric J Rubin, Lindsey R Baden, Stephen Morrissey
The New England Journal of Medicine|March 3, 2021
Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at TreatmentEric J Rubin, Lindsey R Baden, Stephen Morrissey
ASAIO Transactions|April 1, 1988
Intraperitoneal feedingJ Rubin, Q Jones, A Planch, et al.
The New England Journal of Medicine|October 27, 2022
Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 InfectionEric J Rubin, Lindsey R Baden, Stephen Morrissey
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophagesJyothi Rengarajan, Barry R Bloom, Eric J Rubin
American Journal of Clinical Oncology|June 11, 1992
A phase II study of intravenous 6-thioguanine (NSC-752) in advanced colorectal carcinomaJ Rubin, A J Schutt, H C Pitot
Pageof 198

Showing results (451-460 of 1,971) with videos related to

Sort By:
Pageof 198
The New England Journal of Medicine|August 11, 2021
Audio Interview: Monoclonal Antibodies and Booster ShotsEric J Rubin, Lindsey R Baden, Stephen Morrissey
The New England Journal of Medicine|August 4, 2021
Audio Interview: Looking Back and Looking Forward - Part 2Eric J Rubin, Lindsey R Baden, Stephen Morrissey
The New England Journal of Medicine|February 10, 2021
Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing?Eric J Rubin, Lindsey R Baden, Stephen Morrissey
The New England Journal of Medicine|December 22, 2021
Audio Interview: A Potential New Agent to Treat Covid-19Eric J Rubin, Lindsey R Baden, Stephen Morrissey
The New England Journal of Medicine|December 15, 2021
Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?Eric J Rubin, Lindsey R Baden, Stephen Morrissey
The New England Journal of Medicine|March 3, 2021
Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at TreatmentEric J Rubin, Lindsey R Baden, Stephen Morrissey
ASAIO Transactions|April 1, 1988
Intraperitoneal feedingJ Rubin, Q Jones, A Planch, et al.
The New England Journal of Medicine|October 27, 2022
Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 InfectionEric J Rubin, Lindsey R Baden, Stephen Morrissey
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophagesJyothi Rengarajan, Barry R Bloom, Eric J Rubin
American Journal of Clinical Oncology|June 11, 1992
A phase II study of intravenous 6-thioguanine (NSC-752) in advanced colorectal carcinomaJ Rubin, A J Schutt, H C Pitot
Pageof 198